

Droxidopa works by converting into norepinephrine in your body, helping raise blood pressure when you stand. Learn how it works in plain, easy-to-understand language.
Here's the simplest way to understand Droxidopa: your body needs a chemical called norepinephrine to keep your blood pressure steady when you stand up. In people with neurogenic orthostatic hypotension (nOH), the nerves that make norepinephrine are damaged. Droxidopa gives your body a raw ingredient it can convert into norepinephrine, filling in the gap.
Think of it like a supply chain:
The technical term for Droxidopa is a norepinephrine precursor — a molecule that comes "before" the actual active chemical your body needs.
Imagine your body's blood pressure system is like a factory that needs a specific raw material (norepinephrine) to produce its product (stable blood pressure). In nOH, the supply trucks bringing that raw material have broken down. Droxidopa is like sending in a different delivery vehicle that drops off the raw material right at the factory door.
Droxidopa begins working within 1-4 hours of taking a dose. This is why it's taken three times daily — each dose provides a window of blood pressure support. The effects wear off between doses, which is why consistent timing matters.
Your doctor will start you at a low dose (100mg three times daily) and gradually increase it. It may take several days of titration to find the dose that works best for you.
Each dose of Droxidopa provides approximately 6-8 hours of blood pressure support. That's why the three-times-daily schedule is spaced across the day: morning, midday, and late afternoon. The last dose is taken at least 3 hours before bedtime to avoid supine hypertension while sleeping.
There are a few medications used for orthostatic hypotension, but Droxidopa is unique in how it works:
Midodrine is an alpha-1 agonist — it directly tells blood vessels to constrict. Droxidopa takes a different approach: it provides the building blocks for your body to make norepinephrine naturally. Both raise blood pressure, but through different mechanisms.
Midodrine is often tried first because it's cheaper and widely available. Droxidopa may be preferred when Midodrine isn't effective enough or causes too many side effects.
Fludrocortisone is a steroid that increases blood volume by making your kidneys retain sodium and water. It doesn't target blood vessels directly the way Droxidopa does. Fludrocortisone works through a completely different pathway and is often used alongside Droxidopa or Midodrine rather than as a direct replacement.
Droxidopa is the only FDA-approved medication that replaces norepinephrine directly. This makes it particularly well-suited for patients with neurogenic orthostatic hypotension specifically — where the problem is nerve damage that reduces norepinephrine production. For other types of low blood pressure, Droxidopa may not be as effective. For more on alternatives, see alternatives to Droxidopa.
The same mechanism that helps raise blood pressure when standing can raise it too high when lying down. This is why Droxidopa carries a boxed warning for supine hypertension. It's a direct consequence of how the drug works — you can't selectively boost blood pressure only when standing.
Droxidopa works by giving your body the raw materials to make norepinephrine — the chemical your damaged nerves can no longer produce in sufficient quantities. It's a targeted, logical approach to neurogenic orthostatic hypotension that fills a gap other medications don't address. Understanding how it works helps you use it effectively and watch for the right side effects.
For more about Droxidopa, see our guides on uses and dosage, drug interactions, and how to save money.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.